Astec LifeSciences Limited has announced its Unaudited Financial Results for the Quarter and Half Year ended 30th September, 2023 with a consolidated total income of Rs. 111.8 crore in Q2FY24 and a consolidated EBITDA loss of Rs. 2.4 crore in the same period.